Cargando…
Epstein-Barr Virus Genome Deletions in Epstein-Barr Virus-Positive T/NK Cell Lymphoproliferative Diseases
The main target cells for Epstein-Barr virus (EBV) infection and persistence are B lymphocytes, although T and NK cells can also become infected. In this paper, we characterize the EBV present in 21 pediatric and adult patients who were treated in France for a range of diseases that involve infectio...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9215254/ https://www.ncbi.nlm.nih.gov/pubmed/35612313 http://dx.doi.org/10.1128/jvi.00394-22 |
_version_ | 1784731171873095680 |
---|---|
author | Wongwiwat, Wiyada Fournier, Benjamin Bassano, Irene Bayoumy, Amr Elgueta Karstegl, Claudio Styles, Christine Bridges, Ray Lenoir, Christelle BoutBoul, David Moshous, Despina Neven, Bénédicte Kanda, Teru Morgan, Rhys G. White, Robert E. Latour, Sylvain Farrell, Paul J. |
author_facet | Wongwiwat, Wiyada Fournier, Benjamin Bassano, Irene Bayoumy, Amr Elgueta Karstegl, Claudio Styles, Christine Bridges, Ray Lenoir, Christelle BoutBoul, David Moshous, Despina Neven, Bénédicte Kanda, Teru Morgan, Rhys G. White, Robert E. Latour, Sylvain Farrell, Paul J. |
author_sort | Wongwiwat, Wiyada |
collection | PubMed |
description | The main target cells for Epstein-Barr virus (EBV) infection and persistence are B lymphocytes, although T and NK cells can also become infected. In this paper, we characterize the EBV present in 21 pediatric and adult patients who were treated in France for a range of diseases that involve infection of T or NK cells. Of these 21 cases, 5 pediatric patients (21%) and 11 adult patients (52%) were of Caucasian origin. In about 30% of the cases, some of the EBV genomes contain a large deletion. The deletions are different in every patient but tend to cluster near the BART region of the viral genome. Detailed investigation of a family in which several members have persistent T or NK cell infection by EBV indicates that the virus genome deletions arise or are selected independently in each individual patient. Genome sequence polymorphisms in the EBV in these T or NK cell diseases reflect the geographic origin of the patient and not a distinct type of EBV (the 21 cases studied included examples of both type 1 and type 2 EBV infection). Using virus produced from type 1 or type 2 EBV genomes cloned in bacterial artificial chromosome (BAC) vectors, we demonstrate infection of T cells in cord blood from healthy donors. Our results are consistent with transient infection of some T cells being part of normal asymptomatic infection by EBV in young children. IMPORTANCE EBV contributes to several types of human cancer. Some cancers and nonmalignant lymphoproliferative diseases involving T or NK cells contain EBV. These diseases are relatively frequent in Japan and China and have been shown sometimes to have deletions in the EBV genome in the disease cells. We identify further examples of deletions within the EBV genome associated with T or NK cell diseases, and we provide evidence that the virus genomes with these deletions are most likely selected in the individual cases, rather than being transmitted between people during infection. We demonstrate EBV infection of cord blood T cells by highly characterized, cloned EBV genomes and suggest that transient infection of T cells may be part of normal asymptomatic infection by EBV in young children. |
format | Online Article Text |
id | pubmed-9215254 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | American Society for Microbiology |
record_format | MEDLINE/PubMed |
spelling | pubmed-92152542022-06-23 Epstein-Barr Virus Genome Deletions in Epstein-Barr Virus-Positive T/NK Cell Lymphoproliferative Diseases Wongwiwat, Wiyada Fournier, Benjamin Bassano, Irene Bayoumy, Amr Elgueta Karstegl, Claudio Styles, Christine Bridges, Ray Lenoir, Christelle BoutBoul, David Moshous, Despina Neven, Bénédicte Kanda, Teru Morgan, Rhys G. White, Robert E. Latour, Sylvain Farrell, Paul J. J Virol Virus-Cell Interactions The main target cells for Epstein-Barr virus (EBV) infection and persistence are B lymphocytes, although T and NK cells can also become infected. In this paper, we characterize the EBV present in 21 pediatric and adult patients who were treated in France for a range of diseases that involve infection of T or NK cells. Of these 21 cases, 5 pediatric patients (21%) and 11 adult patients (52%) were of Caucasian origin. In about 30% of the cases, some of the EBV genomes contain a large deletion. The deletions are different in every patient but tend to cluster near the BART region of the viral genome. Detailed investigation of a family in which several members have persistent T or NK cell infection by EBV indicates that the virus genome deletions arise or are selected independently in each individual patient. Genome sequence polymorphisms in the EBV in these T or NK cell diseases reflect the geographic origin of the patient and not a distinct type of EBV (the 21 cases studied included examples of both type 1 and type 2 EBV infection). Using virus produced from type 1 or type 2 EBV genomes cloned in bacterial artificial chromosome (BAC) vectors, we demonstrate infection of T cells in cord blood from healthy donors. Our results are consistent with transient infection of some T cells being part of normal asymptomatic infection by EBV in young children. IMPORTANCE EBV contributes to several types of human cancer. Some cancers and nonmalignant lymphoproliferative diseases involving T or NK cells contain EBV. These diseases are relatively frequent in Japan and China and have been shown sometimes to have deletions in the EBV genome in the disease cells. We identify further examples of deletions within the EBV genome associated with T or NK cell diseases, and we provide evidence that the virus genomes with these deletions are most likely selected in the individual cases, rather than being transmitted between people during infection. We demonstrate EBV infection of cord blood T cells by highly characterized, cloned EBV genomes and suggest that transient infection of T cells may be part of normal asymptomatic infection by EBV in young children. American Society for Microbiology 2022-05-25 /pmc/articles/PMC9215254/ /pubmed/35612313 http://dx.doi.org/10.1128/jvi.00394-22 Text en Copyright © 2022 Wongwiwat et al. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Virus-Cell Interactions Wongwiwat, Wiyada Fournier, Benjamin Bassano, Irene Bayoumy, Amr Elgueta Karstegl, Claudio Styles, Christine Bridges, Ray Lenoir, Christelle BoutBoul, David Moshous, Despina Neven, Bénédicte Kanda, Teru Morgan, Rhys G. White, Robert E. Latour, Sylvain Farrell, Paul J. Epstein-Barr Virus Genome Deletions in Epstein-Barr Virus-Positive T/NK Cell Lymphoproliferative Diseases |
title | Epstein-Barr Virus Genome Deletions in Epstein-Barr Virus-Positive T/NK Cell Lymphoproliferative Diseases |
title_full | Epstein-Barr Virus Genome Deletions in Epstein-Barr Virus-Positive T/NK Cell Lymphoproliferative Diseases |
title_fullStr | Epstein-Barr Virus Genome Deletions in Epstein-Barr Virus-Positive T/NK Cell Lymphoproliferative Diseases |
title_full_unstemmed | Epstein-Barr Virus Genome Deletions in Epstein-Barr Virus-Positive T/NK Cell Lymphoproliferative Diseases |
title_short | Epstein-Barr Virus Genome Deletions in Epstein-Barr Virus-Positive T/NK Cell Lymphoproliferative Diseases |
title_sort | epstein-barr virus genome deletions in epstein-barr virus-positive t/nk cell lymphoproliferative diseases |
topic | Virus-Cell Interactions |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9215254/ https://www.ncbi.nlm.nih.gov/pubmed/35612313 http://dx.doi.org/10.1128/jvi.00394-22 |
work_keys_str_mv | AT wongwiwatwiyada epsteinbarrvirusgenomedeletionsinepsteinbarrviruspositivetnkcelllymphoproliferativediseases AT fournierbenjamin epsteinbarrvirusgenomedeletionsinepsteinbarrviruspositivetnkcelllymphoproliferativediseases AT bassanoirene epsteinbarrvirusgenomedeletionsinepsteinbarrviruspositivetnkcelllymphoproliferativediseases AT bayoumyamr epsteinbarrvirusgenomedeletionsinepsteinbarrviruspositivetnkcelllymphoproliferativediseases AT elguetakarsteglclaudio epsteinbarrvirusgenomedeletionsinepsteinbarrviruspositivetnkcelllymphoproliferativediseases AT styleschristine epsteinbarrvirusgenomedeletionsinepsteinbarrviruspositivetnkcelllymphoproliferativediseases AT bridgesray epsteinbarrvirusgenomedeletionsinepsteinbarrviruspositivetnkcelllymphoproliferativediseases AT lenoirchristelle epsteinbarrvirusgenomedeletionsinepsteinbarrviruspositivetnkcelllymphoproliferativediseases AT boutbouldavid epsteinbarrvirusgenomedeletionsinepsteinbarrviruspositivetnkcelllymphoproliferativediseases AT moshousdespina epsteinbarrvirusgenomedeletionsinepsteinbarrviruspositivetnkcelllymphoproliferativediseases AT nevenbenedicte epsteinbarrvirusgenomedeletionsinepsteinbarrviruspositivetnkcelllymphoproliferativediseases AT kandateru epsteinbarrvirusgenomedeletionsinepsteinbarrviruspositivetnkcelllymphoproliferativediseases AT morganrhysg epsteinbarrvirusgenomedeletionsinepsteinbarrviruspositivetnkcelllymphoproliferativediseases AT whiteroberte epsteinbarrvirusgenomedeletionsinepsteinbarrviruspositivetnkcelllymphoproliferativediseases AT latoursylvain epsteinbarrvirusgenomedeletionsinepsteinbarrviruspositivetnkcelllymphoproliferativediseases AT farrellpaulj epsteinbarrvirusgenomedeletionsinepsteinbarrviruspositivetnkcelllymphoproliferativediseases |